NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MIMOSA Diagnostics

MIMOSA Diagnostics

Private
TorontoHealthcare & Life Scienceshttps://www.mimosadiagnostics.com/

Last Round

VC Round

Jun 10, 2024

Total Funding Raised

$168,000

Company Overview

MIMOSA Diagnostics is a medical device company that has developed a handheld, multispectral skin tissue imaging device and data platform for early and accurate diagnosis of a wide range of skin tissue injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Healthcare Analytics, Telemedicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

point-of-care imagingtissue health monitoringmultispectral imagingwound care technologymedical devicehardware as a serviceHaaStissue oximetryremote patient monitoringRPMhealth equityclinical diagnostic toolnear-infrared imagingdigital healthmedtechAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MIMOSA Diagnostics Comparables

Compare MIMOSA Diagnostics with similar companies based on industry and business-model similarity.

MIMOSA Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kent Imaging
87%
WoundVision
85%
Swift Medical
84%

MIMOSA Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 10, 2024
GrantMar 27, 2024
Convertible DebtJul 17, 2023
GrantDec 20, 2020
SeedMay 6, 2020
Grant
Apr 1, 2020

Key People

Founding team and executive leadership

Karen Cross

Co-Founder And CEO

Founding Team

Paul Weber

Advisor To The CEO Founder

Founding Team

Kevin Weitzman

Chief Financial Officer, Board Member

Executive Team

MIMOSA Diagnostics Investors

Notable investors and investment history

MIMOSA Diagnostics investors
InvestorRounds
Maple Leaf AngelsSeed
Kindling Investment PartnersVC Round
Tidal Venture PartnersConvertible Debt
BDC CapitalSeed
National Research Council CanadaGrant
Kern Venture GroupVC Round
MEDTEQ+Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 6, 2020

    Raised capital from BDC Capital, Maple Leaf Angels, and MEDTEQ+.

MIMOSA Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MIMOSA Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MIMOSA Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range35
Year Founded2016
Last FundingJun 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.